5407972025-07-012025-09-305407972025-09-305407972025-03-315407972025-04-012025-09-305407972025-07-012025-09-30in-capmkt:OtherExpenses1Member5407972025-07-012025-09-30in-capmkt:OtherExpenses2Member5407972025-07-012025-09-30in-capmkt:OtherExpenses3Member5407972025-07-012025-09-30in-capmkt:OtherExpenses4Member5407972025-04-012025-09-30in-capmkt:OtherExpenses1Member5407972025-04-012025-09-30in-capmkt:OtherExpenses2Member5407972025-04-012025-09-30in-capmkt:OtherExpenses3Member5407972025-04-012025-09-30in-capmkt:OtherExpenses4Member5407972025-07-012025-09-30in-capmkt:ReportableSegments1Member5407972025-07-012025-09-30in-capmkt:ReportableSegments2Member5407972025-04-012025-09-30in-capmkt:ReportableSegments1Member5407972025-04-012025-09-30in-capmkt:ReportableSegments2Member5407972025-07-012025-09-30in-capmkt:ReportableSegments1Member5407972025-07-012025-09-30in-capmkt:ReportableSegments2Member5407972025-04-012025-09-30in-capmkt:ReportableSegments1Member5407972025-04-012025-09-30in-capmkt:ReportableSegments2Member5407972025-07-012025-09-30in-capmkt:ReportableSegments1Member5407972025-09-30in-capmkt:ReportableSegments1Member5407972025-07-012025-09-30in-capmkt:ReportableSegments2Member5407972025-09-30in-capmkt:ReportableSegments2Member5407972025-07-012025-09-30in-capmkt:ReportableSegments1Member5407972025-09-30in-capmkt:ReportableSegments1Member5407972025-07-012025-09-30in-capmkt:ReportableSegments2Member5407972025-09-30in-capmkt:ReportableSegments2Member5407972025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15407972025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25407972025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15407972025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss2iso4217:INRiso4217:INRxbrli:shares540797SHALBYNOTLISTEDINE597J01018SHALBY LIMITEDMain BoardEquity2025-04-012026-03-312025-11-132025-11-05INRMillionsQuarterlySecond quarterMulti segment2025-11-1316:00:002025-11-1318:05:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated2854320000447500002899070000167050000312140000-12638000045206000096450000173690000163332000027083300001907400000190740000142750000-24790000117960000072780000000072780000-70470000231000083850000-1106000013370000-110700001075150000100.680.68000.680.68Notes <BR> 1. The above unaudited consolidated financial results for the quarter and half year ended September 30, 2025 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the company at their respective meetings held on November 13, 2025. The Statutory Auditors of the Company have carried out a Limited Review for said unaudited financial results. <BR> 2. These financial results have been prepared in accordance with Indian Accounting Standards (Ind- AS) as prescribed under section 133 of Companies Act 2013 read with Rule 3 of the Companies (Indian Accounting Standards) Rules 2015 and relevant amendment thereafter. <BR> 3. Shalby Limited Employees Welfare Trust has acquired 7,00,000 Equity Shares of Shalby Limited in June 2022 through market purchase pursuant to Employee Stock Option Scheme-2021. Company has granted all 7,00,000 Stock Options to eligible employees, out of which total 4,28,765 Stock Options were lapsed and 2,05,235 Options were vested and exercised by eligible employees. <BR> <BR> In accordance with the resolution passed by the Nomination and Remuneration Committee, the Company has granted 97,000 stock options from the pool of 4,28,765 lapsed options and as of September 30, 2025, a total of 1,09,000 stock options remain active. <BR> 4. The consolidated financial result includes the results of the Company and 14 Subsidiary companies (Covering 4 stepdown subsidiaies). The company together with its subsidiaries is herein referred to as the "Group". <BR> 5. The Group is not a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P /2018/144 dated November 26, 2018. <BR> 6. The Code on Social Security, 2020 ('Code') relating to employee benefits during employment and post-employment benefits has received Presidential assent and has been published in the Gazette of India. However, the effective date of the Code and final rules for quantifying the financial impact are yet to be notified. The Group will assess the impact of the Code when relevant provisions are notified and will record related impact, if any, in the period the Code becomes effective. <BR> 7. As per Indian Accounting Standard ("Ind AS") 108 - "Segment Reporting", segment information has been provided in Consolidated Financial Results. The business segments of the company comprise of Healthcare Activities & Manufacturing of Implant. Disclosure for the same is given in the separate note attached herewith in Annexure I. <BR> 8. Previous period figures have been re-grouped, re-cast and re-arranged wherever considered necessary to make it comparable.2025-04-012025-09-30UnauditedConsolidated58185900001148300005933420000321620000605550000-192380000917160000190160000338920000333512000055161500004172700000417270000326190000-5848000026771000001495600000000149560000-7505000074510000173050000-2350000097990000-234900001075150000101.391.39001.391.39Materials and Consumables356380000Fees to Doctors and Consultants686130000Other Operative Expenses242300000Other Expenses348510000Materials and Consumables822130000Fees to Doctors and Consultants1390600000Other Operative Expenses478720000Other Expenses6436700008520430000539090000056859000054380000012878000000000167760000167760000204600003924300001088134000034663500008724200001858340000189680000350000025253000031733200000303230000694290000000178242400001075150000894526000010020410000790000010028310000146829000000036200001471910000746600006070700000430180000258382000033988500002434000012855400001309880000212830000492156000023825000035790000165100000521211000000779593000017824240000Healthcare Services2525660000Manufacturing & Trading of Implants328660000Healthcare Services5209300000Manufacturing & Trading of Implants6092900002854320000581859000028543200005818590000Healthcare Services255940000Manufacturing & Trading of Implants-65200000Healthcare Services581620000Manufacturing & Trading of Implants-164350000190740000417270000190740000417270000Healthcare Services12519000000Manufacturing & Trading of Implants530523000017824230000017824230000Healthcare Services-4273500000Manufacturing & Trading of Implants-3522410000-77959100000-7795910000190160000-274240000-1183600000-71740000-5210000-4470000-7763000001256600000-26180000-7100000338920000013170000048000001500000013360000000-632500000-618800000-50560000366710000000228240000013847000000000000145000080992000000000000000000000087000000106800000-6929700000000002900000101272000041276000026970000017695000000396330000-1581700000-158170000347850000189680000Remeasurement of the defined benefit plans-2350000(Gain)/ Loss arising from translating the financial statement of foreign Operation-68940000-71290000Remeasurement of the defined benefit plans-1570000(Gain)/ Loss arising from translating the financial statement of foreign Operation-74030000-75600000-820000-550000-70470000-75050000